{"id":3101,"date":"2022-03-22T14:00:02","date_gmt":"2022-03-22T04:00:02","guid":{"rendered":"\/eu-uk\/?p=3101"},"modified":"2022-03-23T05:58:17","modified_gmt":"2022-03-22T19:58:17","slug":"video-proactive-investors-march-2022","status":"publish","type":"post","link":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/","title":{"rendered":"VIDEO | Proactive Investors &#8211; March 2022"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Orthocell Managing Director, Paul Anderson, spoke with Andrew Scott from Proactive Investors to discuss Australian regulatory (TGA) approval for our Remplir\u2122 nerve repair device.<\/span><\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/BEl_OKk8d4I\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in the OrthoATI\u2122 rotator cuff tendon study.<\/p>\n","protected":false},"author":2,"featured_media":3102,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[3,1],"tags":[],"class_list":["post-3101","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-media","category-video"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.8 - aioseo.com -->\n\t<meta name=\"description\" content=\"Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in the OrthoATI\u2122 rotator cuff tendon study.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Orthocell\"\/>\n\t<link rel=\"canonical\" href=\"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.8\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_GB\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Orthocell EU\/UK -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"VIDEO | Proactive Investors \u2013 March 2022 - Orthocell EU\/UK\" \/>\n\t\t<meta property=\"og:description\" content=\"Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in the OrthoATI\u2122 rotator cuff tendon study.\" \/>\n\t\t<meta property=\"og:url\" content=\"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2022-03-22T04:00:02+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2022-03-22T19:58:17+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"VIDEO | Proactive Investors \u2013 March 2022 - Orthocell EU\/UK\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in the OrthoATI\u2122 rotator cuff tendon study.\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2022\\\/03\\\/22\\\/video-proactive-investors-march-2022\\\/#blogposting\",\"name\":\"VIDEO | Proactive Investors \\u2013 March 2022 - Orthocell EU\\\/UK\",\"headline\":\"VIDEO | Proactive Investors &#8211; March 2022\",\"author\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2022\\\/03\\\/Screen-Shot-2022-03-23-at-6.56.53-am.png\",\"width\":1705,\"height\":959},\"datePublished\":\"2022-03-22T14:00:02+10:00\",\"dateModified\":\"2022-03-23T05:58:17+10:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2022\\\/03\\\/22\\\/video-proactive-investors-march-2022\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2022\\\/03\\\/22\\\/video-proactive-investors-march-2022\\\/#webpage\"},\"articleSection\":\"Media, Video\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2022\\\/03\\\/22\\\/video-proactive-investors-march-2022\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/#listItem\",\"name\":\"Video\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/#listItem\",\"position\":2,\"name\":\"Video\",\"item\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2022\\\/03\\\/22\\\/video-proactive-investors-march-2022\\\/#listItem\",\"name\":\"VIDEO | Proactive Investors &#8211; March 2022\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2022\\\/03\\\/22\\\/video-proactive-investors-march-2022\\\/#listItem\",\"position\":3,\"name\":\"VIDEO | Proactive Investors &#8211; March 2022\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/video\\\/#listItem\",\"name\":\"Video\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\",\"name\":\"Orthocell EU\\\/UK\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/\",\"name\":\"Orthocell\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2022\\\/03\\\/22\\\/video-proactive-investors-march-2022\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0aab809366bb46167bf34d1c56223f53c568b96a5870f19d01139e3e4a20c2f1?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Orthocell\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2022\\\/03\\\/22\\\/video-proactive-investors-march-2022\\\/#webpage\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2022\\\/03\\\/22\\\/video-proactive-investors-march-2022\\\/\",\"name\":\"VIDEO | Proactive Investors \\u2013 March 2022 - Orthocell EU\\\/UK\",\"description\":\"Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in the OrthoATI\\u2122 rotator cuff tendon study.\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2022\\\/03\\\/22\\\/video-proactive-investors-march-2022\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2022\\\/03\\\/Screen-Shot-2022-03-23-at-6.56.53-am.png\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2022\\\/03\\\/22\\\/video-proactive-investors-march-2022\\\/#mainImage\",\"width\":1705,\"height\":959},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2022\\\/03\\\/22\\\/video-proactive-investors-march-2022\\\/#mainImage\"},\"datePublished\":\"2022-03-22T14:00:02+10:00\",\"dateModified\":\"2022-03-23T05:58:17+10:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#website\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/\",\"name\":\"Orthocell EU\\\/UK\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"VIDEO | Proactive Investors \u2013 March 2022 - Orthocell EU\/UK","description":"Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in the OrthoATI\u2122 rotator cuff tendon study.","canonical_url":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/#blogposting","name":"VIDEO | Proactive Investors \u2013 March 2022 - Orthocell EU\/UK","headline":"VIDEO | Proactive Investors &#8211; March 2022","author":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"publisher":{"@id":"\/eu-uk\/#organization"},"image":{"@type":"ImageObject","url":"\/eu-uk\/wp-content\/uploads\/sites\/6\/2022\/03\/Screen-Shot-2022-03-23-at-6.56.53-am.png","width":1705,"height":959},"datePublished":"2022-03-22T14:00:02+10:00","dateModified":"2022-03-23T05:58:17+10:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/#webpage"},"isPartOf":{"@id":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/#webpage"},"articleSection":"Media, Video"},{"@type":"BreadcrumbList","@id":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/orthocell.com\/eu-uk#listItem","position":1,"name":"Home","item":"https:\/\/orthocell.com\/eu-uk","nextItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/video\/#listItem","name":"Video"}},{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/video\/#listItem","position":2,"name":"Video","item":"\/eu-uk\/blog\/category\/video\/","nextItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/#listItem","name":"VIDEO | Proactive Investors &#8211; March 2022"},"previousItem":{"@type":"ListItem","@id":"https:\/\/orthocell.com\/eu-uk#listItem","name":"Home"}},{"@type":"ListItem","@id":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/#listItem","position":3,"name":"VIDEO | Proactive Investors &#8211; March 2022","previousItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/video\/#listItem","name":"Video"}}]},{"@type":"Organization","@id":"\/eu-uk\/#organization","name":"Orthocell EU\/UK","url":"\/eu-uk\/"},{"@type":"Person","@id":"\/eu-uk\/blog\/author\/hcartres\/#author","url":"\/eu-uk\/blog\/author\/hcartres\/","name":"Orthocell","image":{"@type":"ImageObject","@id":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/0aab809366bb46167bf34d1c56223f53c568b96a5870f19d01139e3e4a20c2f1?s=96&d=mm&r=g","width":96,"height":96,"caption":"Orthocell"}},{"@type":"WebPage","@id":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/#webpage","url":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/","name":"VIDEO | Proactive Investors \u2013 March 2022 - Orthocell EU\/UK","description":"Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in the OrthoATI\u2122 rotator cuff tendon study.","inLanguage":"en-GB","isPartOf":{"@id":"\/eu-uk\/#website"},"breadcrumb":{"@id":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/#breadcrumblist"},"author":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"creator":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"image":{"@type":"ImageObject","url":"\/eu-uk\/wp-content\/uploads\/sites\/6\/2022\/03\/Screen-Shot-2022-03-23-at-6.56.53-am.png","@id":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/#mainImage","width":1705,"height":959},"primaryImageOfPage":{"@id":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/#mainImage"},"datePublished":"2022-03-22T14:00:02+10:00","dateModified":"2022-03-23T05:58:17+10:00"},{"@type":"WebSite","@id":"\/eu-uk\/#website","url":"\/eu-uk\/","name":"Orthocell EU\/UK","inLanguage":"en-GB","publisher":{"@id":"\/eu-uk\/#organization"}}]},"og:locale":"en_GB","og:site_name":"Orthocell EU\/UK -","og:type":"article","og:title":"VIDEO | Proactive Investors \u2013 March 2022 - Orthocell EU\/UK","og:description":"Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in the OrthoATI\u2122 rotator cuff tendon study.","og:url":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/","article:published_time":"2022-03-22T04:00:02+00:00","article:modified_time":"2022-03-22T19:58:17+00:00","twitter:card":"summary_large_image","twitter:title":"VIDEO | Proactive Investors \u2013 March 2022 - Orthocell EU\/UK","twitter:description":"Orthocell CEO and Managing Director Paul Anderson spoke with Andrew Scott from Proactive Investors about passing a key milestone in the OrthoATI\u2122 rotator cuff tendon study."},"aioseo_meta_data":[],"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/orthocell.com\/eu-uk\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"\/eu-uk\/blog\/category\/video\/\" title=\"Video\">Video<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tVIDEO | Proactive Investors \u2013 March 2022\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/orthocell.com\/eu-uk"},{"label":"Video","link":"\/eu-uk\/blog\/category\/video\/"},{"label":"VIDEO | Proactive Investors &#8211; March 2022","link":"\/eu-uk\/blog\/2022\/03\/22\/video-proactive-investors-march-2022\/"}],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/3101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=3101"}],"version-history":[{"count":1,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/3101\/revisions"}],"predecessor-version":[{"id":3103,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/3101\/revisions\/3103"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/media\/3102"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=3101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=3101"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=3101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}